OGD2 PHARMA
🏢 View company profile →6Patents
6Active
6Granted
44Portfolio score
Filing activity: Apr 29, 2014 → May 21, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10000575B2 | Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer | Chemistry; Metallurgy | 2 | Active |
| US10745489B2 | Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer | Physics | 0 | Active |
| US10611848B2 | Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity | Chemistry; Metallurgy | 0 | Active |
| US11440968B2 | Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) | Chemistry; Metallurgy | 0 | Active |
| US10669328B2 | Human IgG1 derived antibody with pro-apoptotic activity | Chemistry; Metallurgy | 0 | Active |
| US11697689B2 | Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.